Justin Stebbing
Imperial College London
H-index: 88
Europe-United Kingdom
Top articles of Justin Stebbing
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome | Nature Communications | Terese C Hammond Marco A Purbhoo Sapana Kadel Jerome Ritz Sarah Nikiforow | 2024/2/6 |
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study | Breast Cancer Research and Treatment | Rebecca C Allsopp Qi Guo Karen Page Shradha Bhagani Anna Kasim | 2024/4/6 |
Genes and Race in Colon Cancer | Justin Stebbing Benjamin L Schlechter | 2024/2/1 | |
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer | JCO Precision Oncology | Jacqueline A Shaw Karen Page Evie Wren Elza C de Bruin Ekaterina Kalashnikova | 2024/4 |
Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma | Molecular biotechnology | Peng Wang Zhiqiang Wang Yanke Lin Leandro Castellano Justin Stebbing | 2024/2 |
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS | Respiratory Research | Ioannis Grigoropoulos Georgios Tsioulos Artemis Kastrissianakis Shiran Shapira Orr Green | 2024/4/1 |
LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC). | Lesly Torres-Gonzalez Francesca Battaglin Shivani Soni Yasmine Baca Joanne Xiu | 2024/1/20 | |
Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer | Clinical Cancer Research | Justin Stebbing Andrea J Bullock | 2024/3/28 |
An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma | BMC Medical Genomics | Zhonghai Du Xiuchen Han Liping Zhu Li Li Leandro Castellano | 2024 |
Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma | Advanced Science | Viviana Vella Angeliki Ditsiou Anna Chalari Murat Eravci Sarah K Wooller | 2024/2/14 |
CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth | bioRxiv | Tom Stiff Salih Bayraktar Paola Dama Justin Stebbing Leandro Castellano | 2023 |
Kinome-wide synthetic lethal screen identifies PANK4 as modulator of resistance in glioblastoma | Viviana Vella Angeliki Ditsiou Anna Chalari Murat Eravci Sarah K Wooler | 2023/3/27 | |
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease | Experimental hematology & oncology | Mireia Mato Prado Jisce R Puik Leandro Castellano Elena López-Jiménez Daniel SK Liu | 2023/12/1 |
Comparison of phenomics and cfDNA in a large breast screening population: The Breast Screening and Monitoring Study (BSMS) | Oncogene | Justin Stebbing Panteleimon G. Takis* Caroline J. Sands Lynn Maslen Matthew R. Lewis | 2023/1/24 |
A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data | Heliyon | Zhonghai Du Tongtong Zhang Yanke Lin Guifen Dong Aixiang Li | 2023/11/1 |
A pyroptosis‐related lncRNA signature in bladder cancer | Cancer medicine | Peng Wang Zhiqiang Wang Liping Zhu Yilan Sun Leandro Castellano | 2023/3 |
The mutational landscape of the adult healthy parous and nulliparous human breast | Nature Communications | Biancastella Cereser Angela Yiu Neha Tabassum Lisa Del Bel Belluz Sladjana Zagorac | 2023/9/6 |
Design and reporting of phase III oncology trials with prospective biomarker validation | JNCI: Journal of the National Cancer Institute | Fei Liang Ling Peng Zhengyu Wu Georgios Giamas Justin Stebbing | 2023/2/1 |
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer | Antonino Glaviano Aaron SC Foo Hiu Y Lam Kenneth CH Yap William Jacot | 2023/8/18 | |
The inhibitory properties of a novel, selective LMTK3 kinase inhibitor | International Journal of Molecular Sciences | Alessandro Agnarelli Andrea Lauer Betrán Athanasios Papakyriakou Viviana Vella Mark Samuels | 2023/1/3 |
